Rybelsus®

Semaglutide

Rybelsus® tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus® can be prescribed when other diabetes medicines have been tried without success and should be used together with diet and exercise. Rybelsus® tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating.
more
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
QAR 54.54
QAR 4908.96QAR 54.54
QAR 654.19
60 tablet
Free AirMail shipping Hot
QAR 58.18
QAR 3490.76QAR 58.18
QAR 218.00
30 tablet
Free AirMail shipping Hot
QAR 61.81
QAR 1854.38QAR 61.81
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
QAR 65.45
QAR 5890.79QAR 65.45
QAR 326.91
60 tablet
Free AirMail shipping Hot
QAR 67.27
QAR 4036.22QAR 67.27
QAR 108.91
30 tablet
Free AirMail shipping Hot
QAR 69.09
QAR 2072.57QAR 69.09
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
QAR 78.18
QAR 7036.25QAR 78.18
QAR 326.91
60 tablet
Free AirMail shipping Hot
QAR 80.00
QAR 4799.87QAR 80.00
QAR 108.91
30 tablet
Free AirMail shipping Hot
QAR 81.81
QAR 2454.39QAR 81.81
Rybelsus

Brand(s)

Manufacturer

  • Novo Nordisc India Pvt. Ltd

Disease(s)

  • Type 2 Diabetes Mellitus / High Blood Sugar

Rybelsus® tablets

What is Rybelsus?

Rybelsus tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus can be prescribed when other diabetes medicines have been tried without success, and should be used together with diet and exercise.

Rybelsus tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating. Rybelsus is from the class of medicines called GLP-1 receptor agonists.
Rybelsus is not for treating type 1 diabetes.
Rybelsus was first approved by the FDA on September 20, 2019.

Warnings

You should not use Rybelsus if you have multiple endocrine neoplasia type 2 (tumors in your glands), a personal or family history of medullary thyroid cancer, insulin-dependent diabetes, or diabetic ketoacidosis.
Call your doctor at once if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, a hoarse voice, or shortness of breath.